<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02267447</url>
  </required_header>
  <id_info>
    <org_study_id>CIHR FRN - 133550</org_study_id>
    <nct_id>NCT02267447</nct_id>
  </id_info>
  <brief_title>Cardiovascular Disease Population Risk Tool</brief_title>
  <acronym>CVDPoRT</acronym>
  <official_title>Risk of Cardiovascular Disease in Canada and Burden of Health Behaviours: Development of Population-based Risk Algorithms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ottawa Hospital Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institute for Clinical Evaluative Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Statistics Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ottawa Hospital Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to develop, evaluate, and apply a predictive algorithm for
      assessing CVD risk in the community setting: the Cardiovascular Disease Population Risk Tool
      (CVDPoRT).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This observational study will use the Ontario sample of the Canadian Community Health Survey
      (2001, 2003, 2005; 77,251 respondents) to assess risk factors - focusing on health behaviours
      (physical activity, diet, smoking, and alcohol use). Incident CVD outcomes will be assessed
      through linkage to administrative healthcare databases (619,886 person-years of follow-up
      until 31 December 2011). Socio-demographic factors (age, sex, immigrant status, education)
      and mediating factors such as presence of diabetes and hypertension will be included as
      predictors. Risk prediction models will be developed using competing risks survival analysis.
      The analysis plan adheres to published recommendations for the development of valid risk
      prediction models to limit the risk of over-fitting and improve the quality of predictions.
      Key considerations are fully pre-specifying the predictor variables; appropriate handling of
      missing data; use of flexible functions for continuous predictors; and avoiding data-driven
      variable selection procedures that increase the risk of type I error. The 2007 and 2009
      surveys (approximately 50,000 respondents) will be used for validation. Calibration will be
      assessed overall and in predefined subgroups of importance to clinicians and policymakers.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2000</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Major Cardiovascular Disease Event</measure>
    <time_frame>up to 12 years</time_frame>
    <description>The primary outcome of interest was a major CVD event resulting in hospitalization or sudden death from CVD. Respondents were followed from the survey administration date until the earliest of: incident event, death due to causes other than CVD (defined as a competing risk), loss to follow-up (defined as loss of health care eligibility), or end of study (31 December 2012).</description>
  </primary_outcome>
  <other_outcome>
    <measure>Death Due to Causes Other Than CVD</measure>
    <time_frame>up to 12 years</time_frame>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">104219</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>Derivation cohort</arm_group_label>
    <description>Eligible respondents to the combined 2001, 2003 and 2005 Canadian Community Health Surveys, conducted by Statistics Canada.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Validation cohort</arm_group_label>
    <description>Eligible respondents to the 2007 and 2009 Canadian Community Health Surveys.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The derivation cohort will be eligible respondents to the combined 2001, 2003 and 2005
        Canadian Community Health Surveys, conducted by Statistics Canada. The validation cohort
        will consist of respondents to the 2007 and 2009 surveys.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Respondents to the Canadian Community Health Surveys

        Exclusion Criteria:

          -  Not eligible for Ontario's universal health insurance program

          -  Pregnant

          -  Prior history of heart disease or stroke

          -  Younger than age 20
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2014</study_first_submitted>
  <study_first_submitted_qc>October 14, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 17, 2014</study_first_posted>
  <results_first_submitted>September 27, 2016</results_first_submitted>
  <results_first_submitted_qc>April 26, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">August 7, 2017</results_first_posted>
  <last_update_submitted>April 26, 2017</last_update_submitted>
  <last_update_submitted_qc>April 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiovascular diseases</keyword>
  <keyword>Clinical prediction rule</keyword>
  <keyword>Population projection</keyword>
  <keyword>Risk stratification</keyword>
  <keyword>Health behavior</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The final model parameters will be provided in Predictive Modelling Markup Language (PMML) and Lime questionnaire files; as well, we will provide a mock dataset. These files can be used to generate risk estimates in computer applications.</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Derivation Cohort</title>
          <description>Eligible respondents to the combined 2001, 2003 and 2005 Canadian Community Health Surveys, conducted by Statistics Canada.</description>
        </group>
        <group group_id="P2">
          <title>Validation Cohort</title>
          <description>Eligible respondents to the 2007 and 2009 Canadian Community Health Surveys.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="77251"/>
                <participants group_id="P2" count="26968"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="77251"/>
                <participants group_id="P2" count="26968"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Ontario respondents of CCHS survey cycles 1.1, 2.1, 3.1 and 4.1 (conducted in 2001, 2003, 2005 and 2007, respectively). Respondents were excluded if they were not eligible for Ontario’s universal health insurance program, were pregnant, self-reported a prior history of heart disease or stroke, or were age &lt;20 at the time of survey administration.</population>
      <group_list>
        <group group_id="B1">
          <title>Derivation Cohort</title>
          <description>Eligible respondents to the combined 2001, 2003 and 2005 Canadian Community Health Surveys, conducted by Statistics Canada.</description>
        </group>
        <group group_id="B2">
          <title>Validation Cohort</title>
          <description>Eligible respondents to the 2007/2008 Canadian Community Health Survey.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="77,251"/>
            <count group_id="B2" value="26,968"/>
            <count group_id="B3" value="104219"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48.0" lower_limit="35.0" upper_limit="63.0"/>
                    <measurement group_id="B2" value="51.0" lower_limit="37.0" upper_limit="64.0"/>
                    <measurement group_id="B3" value="49.5" lower_limit="36.0" upper_limit="63.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46.0" lower_limit="35.0" upper_limit="59.0"/>
                    <measurement group_id="B2" value="48.0" lower_limit="35.0" upper_limit="63.0"/>
                    <measurement group_id="B3" value="47.0" lower_limit="35.0" upper_limit="61.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="42185"/>
                    <measurement group_id="B2" value="14801"/>
                    <measurement group_id="B3" value="56986"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="35066"/>
                    <measurement group_id="B2" value="12167"/>
                    <measurement group_id="B3" value="47233"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Major Cardiovascular Disease Event</title>
        <description>The primary outcome of interest was a major CVD event resulting in hospitalization or sudden death from CVD. Respondents were followed from the survey administration date until the earliest of: incident event, death due to causes other than CVD (defined as a competing risk), loss to follow-up (defined as loss of health care eligibility), or end of study (31 December 2012).</description>
        <time_frame>up to 12 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Derivation Cohort</title>
            <description>Eligible respondents to the combined 2001, 2003 and 2005 Canadian Community Health Surveys, conducted by Statistics Canada.</description>
          </group>
          <group group_id="O2">
            <title>Validation Cohort</title>
            <description>Eligible respondents to the 2007 /2008 Canadian Community Health Surveys.</description>
          </group>
        </group_list>
        <measure>
          <title>Major Cardiovascular Disease Event</title>
          <description>The primary outcome of interest was a major CVD event resulting in hospitalization or sudden death from CVD. Respondents were followed from the survey administration date until the earliest of: incident event, death due to causes other than CVD (defined as a competing risk), loss to follow-up (defined as loss of health care eligibility), or end of study (31 December 2012).</description>
          <units>Cardiovascular disease event</units>
          <param>Number</param>
          <units_analyzed>person-years</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="77251"/>
                <count group_id="O2" value="26938"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>person-years</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="687135"/>
                <count group_id="O2" value="131343"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3182"/>
                    <measurement group_id="O2" value="527"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Death Due to Causes Other Than CVD</title>
        <time_frame>up to 12 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Derivation Cohort</title>
            <description>Eligible respondents to the combined 2001, 2003 and 2005 Canadian Community Health Surveys, conducted by Statistics Canada.</description>
          </group>
          <group group_id="O2">
            <title>Validation Cohort</title>
            <description>Eligible respondents to the 2007/2008 Canadian Community Health Surveys.</description>
          </group>
        </group_list>
        <measure>
          <title>Death Due to Causes Other Than CVD</title>
          <units>deaths</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="77251"/>
                <count group_id="O2" value="26968"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3538"/>
                    <measurement group_id="O2" value="979"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>no adverse event assessment/reporting</desc>
      <group_list>
        <group group_id="E1">
          <title>Derivation Cohort</title>
          <description>Eligible respondents to the combined 2001, 2003 and 2005 Canadian Community Health Surveys, conducted by Statistics Canada.</description>
        </group>
        <group group_id="E2">
          <title>Validation Cohort</title>
          <description>Eligible respondents to the 2007/2008 Canadian Community Health Surveys.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Doug Manuel</name_or_title>
      <organization>Ottawa Hospital Research Institute</organization>
      <phone>613-798-5555 ext 19108</phone>
      <email>dmanuel@ohri.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

